High density cultures of embryonic stem cells.

Embryonic stem cells (ESC) have the unique ability to differentiate into a variety of tissue types. However, the realization of regenerative medicine will require the production of large quantities of ESC which subsequently have to be differentiated into the final phenotype. Thus, we sought to develop a simple and scaleable bioprocess to increase densities of ESC to achieve this goal. Using mouse embryonic stem cells (mESC) as a model, by combining automated feeding and culture of mESC on petriperm dishes, cell densities were enhanced up to 6.4 x 10(6) cells/cm2 compared to conventional petri dish culture which only reached 0.2 to 1.4 x 10(6) cells/cm2. It was found that mESC from all experiments maintained excellent viability, pluripotency, and genetic stability after growing for 6 days in petriperm cultures with automated feeding. The expression of Oct-4 transcription factor was observed in all cultures, mESC formed embryoid bodies in differentiated cultures and teratomas in SCID mice, confirming their pluripotency, and karyotype of the cultures was normal. This culture method was stable for routine passaging and a second mESC cell line was shown to perform in a similar manner on petriperm with automated feeding. This work represents an important step towards achieving high density cultures of ESC.

[1]  J. Miyazaki,et al.  Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells , 2000, Nature Genetics.

[2]  J G Bender,et al.  Effects of CD34+ cell selection and perfusion on ex vivo expansion of peripheral blood mononuclear cells. , 1995, Blood.

[3]  D. Solter,et al.  Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[4]  H. Schöler,et al.  Formation of Pluripotent Stem Cells in the Mammalian Embryo Depends on the POU Transcription Factor Oct4 , 1998, Cell.

[5]  Robert L Sah,et al.  Perfusion increases cell content and matrix synthesis in chondrocyte three-dimensional cultures. , 2002, Tissue engineering.

[6]  Steve Oh,et al.  Expansion of pluripotent human embryonic stem cells on human feeders , 2004, Biotechnology and bioengineering.

[7]  Stewart Craig,et al.  Comparison of a Static Process and a Bioreactor-based Process for the GMP Manufacture of Autologous Xcellerated T Cells for Clinical Trials , 2003 .

[8]  Gordana Vunjak-Novakovic,et al.  Perfusion improves tissue architecture of engineered cardiac muscle. , 2002, Tissue engineering.

[9]  D. Lauffenburger,et al.  Leukemia inhibitory factor (LIF) concentration modulates embryonic stem cell self-renewal and differentiation independently of proliferation. , 2000, Biotechnology and bioengineering.

[10]  Bernhard O. Palsson,et al.  Large-scale Expansion of Human Stem and Progenitor Cells From Bone Marrow Mononuclear Cells in Continuous Perfusion Cultures , 1993 .

[11]  V. Ling,et al.  In vitro differentiation of embryonic stem cells: Immunophenotypic analysis of cultured embryoid bodies , 1997, Journal of cellular physiology.

[12]  Steve Oh,et al.  Assessment of Stem Cell Markers During Long-Term Culture of Mouse Embryonic Stem Cells , 2004, Cytotechnology.

[13]  D K Robinson,et al.  Industrial choices for protein production by large-scale cell culture. , 2001, Current opinion in biotechnology.

[14]  George Q. Daley,et al.  Derivation of embryonic germ cells and male gametes from embryonic stem cells , 2004, Nature.

[15]  P. Murray,et al.  The regulation of embryonic stem cell differentiation by leukaemia inhibitory factor (LIF). , 2001, Differentiation; research in biological diversity.

[16]  P. Perrin,et al.  An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion-reactor system. , 1995, Vaccine.

[17]  J. D. Yang,et al.  Achievement of high cell density and high antibody productivity by a controlled-fed perfusion bioreactor process. , 2000, Biotechnology and bioengineering.

[18]  John K. Heath,et al.  Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides , 1988, Nature.

[19]  C. Dani,et al.  Differentiation of embryonic stem cells into adipocytes in vitro. , 1997, Journal of cell science.

[20]  Denis Drapeau,et al.  Spin Filter Perfusion System for High Density Cell Culture: Production of Recombinant Urinary Type Plasminogen Activator in CHO Cells , 1990, Bio/Technology.

[21]  D. Lauffenburger,et al.  Ligand/Receptor Signaling Threshold (LIST) Model Accounts for gp130‐Mediated Embryonic Stem Cell Self‐Renewal Responses to LIF and HIL‐6 , 2002, Stem cells.

[22]  J E Prenosil,et al.  Development of an on-line monitoring system of human keratinocyte growth by image analysis and its application to bioreactor culture. , 2000, Biotechnology and bioengineering.

[23]  Donald Metcalf,et al.  Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells , 1988, Nature.

[24]  M. Salto‐Tellez,et al.  AFP+, ESC‐Derived Cells Engraft and Differentiate into Hepatocytes in Vivo , 2002, Stem cells.

[25]  D. Metcalf.  The Unsolved Enigmas of Leukemia Inhibitory Factor , 2003, Stem cells.

[26]  Austin G Smith,et al.  Differentiation inhibiting activity is produced in matrix-associated and diffusible forms that are generated by alternate promoter usage , 1990, Cell.

[27]  Pratima Kundu,et al.  Generation of Hepatocyte-Like Cells from Human Embryonic Stem Cells , 2003, Cell transplantation.

[28]  Masahiro Kino-oka,et al.  Growth of Human Keratinocytes on Hydrophilic Film Support and Application to Bioreactor Culture , 1998 .

[29]  David W. Melton,et al.  Targetted correction of a mutant HPRT gene in mouse embryonic stem cells , 1987, Nature.

[30]  J F Elliott,et al.  Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. , 2001, Diabetes.

[31]  Antonios G Mikos,et al.  Flow perfusion culture of marrow stromal osteoblasts in titanium fiber mesh. , 2003, Journal of biomedical materials research. Part A.

[32]  R. McKay,et al.  Differentiation of Embryonic Stem Cells to Insulin-Secreting Structures Similar to Pancreatic Islets , 2001, Science.

[33]  Austin G Smith,et al.  Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture , 2003, Nature Biotechnology.

[34]  Benjamin E. Reubinoff,et al.  Neural progenitors from human embryonic stem cells , 2001, Nature Biotechnology.

[35]  H. Schöler,et al.  Derivation of Oocytes from Mouse Embryonic Stem Cells , 2003, Science.

[36]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[37]  J. Evans,et al.  Glycolipid stage-specific embryonic antigens (SSEA-1) in kidneys of male and female C57BL/6J and beige adult mice. , 1988, Journal of lipid research.

[38]  J. Nichols,et al.  Maintenance of the pluripotential phenotype of embryonic stem cells through direct activation of gp130 signalling pathways , 1994, Mechanisms of Development.